BioCellgraft -

“We are excited to partner with Celularity to bring these exceptional regenerative therapies to the dental market in the United States. The existing data supports the tremendous opportunity we have to assist oral healthcare practitioners with extremely difficult indications which often involve painful procedures that are long and require many visits"

"Oral health is fundamental to overall health. This opportunity to manufacture placental-derived biomaterials for BioCellgraft will bring our exceptional, proven biomaterial technology to the treatment of oral healthcare concerns and fill the treatment gap for patients that suffer from soft tissue and hard tissue conditions”

"We are the pioneers of bringing next-level regenerative health solutions to the dental markets and doing so with the world’s first injectable regenerative therapy to dentistry that will help thousands upon thousands of people every year.”